On this week's podcast, we spoke about progress for FDA Commissioner-nominee Robert Califf, and a committee report critical of companies and FDA policies over duodenoscope infection outbreaks. We also discussed company updates from the JP Morgan Healthcare Conference, a federal preemption update and CDRH's two-year policy agenda.
